NEW YORK (GenomeWeb News) – Sanford-Burnham Medical Research Institute said this week that CEO John Reed is leaving his post at the institute to become head of Roche Pharma Research and Early Development and to serve on the firm's corporate executive committee. Sanford-Burnham's current President, Kristiina Vuori, will take over Reed's responsibilities on an interim basis while the institute seeks his replacement.

After the management transition process is complete, Reed will continue to hold an adjunct professor spot with the institute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.